File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.6004/jnccn.2013.0072
- Scopus: eid_2-s2.0-84877964841
- WOS: WOS:000318752600007
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Thymomas and thymic carcinomas
Title | Thymomas and thymic carcinomas |
---|---|
Authors | Ettinger, David S.Riely, Gregory J.Akerley, WallaceBorghaei, HosseinChang, Andrew C.Cheney, Richard T.Chirieac, Lucian R.D'Amico, Thomas A.Demmy, Todd L.Govindan, RamaswamyGrannis, Frederic W.Grant, Stefan C.Horn, LeoraJahan, Thierry M.Komaki, RitsukoKong, Feng MingKris, Mark G.Krug, Lee M.Lackner, Rudy P.Lennes, Inga T.Loo, Billy W.Martins, RenatoOtterson, Gregory A.Patel, Jyoti D.Pinder-Schenck, Mary C.Pisters, Katherine M.Reckamp, KarenRohren, EricShapiro, Theresa A.Swanson, Scott J.Tauer, KurtWood, Douglas E.Yang, Stephen C.Gregory, KristinaHughes, Miranda |
Issue Date | 2013 |
Citation | JNCCN Journal of the National Comprehensive Cancer Network, 2013, v. 11, n. 5, p. 562-576 How to Cite? |
Abstract | Masses in the anterior mediastinum can be neoplasms (eg, thymomas, thymic carcinomas, or lung metastases) or nonneoplastic conditions (eg, intrathoracic goiter). Thymomas are the most common primary tumor in the anterior mediastinum, although they are rare. Thymic carcinomas are very rare. Thymomas and thymic carcinomas originate in the thymus. Although thymomas can spread locally, they are much less invasive than thymic carcinomas. Patients with thymomas have 5-year survival rates of approximately 78%. However, 5-year survival rates for thymic carcinomas are only approximately 40%. These guidelines outline the evaluation, treatment, and management of these mediastinal tumors. Copyright © 2013 by the National Comprehensive Cancer Network. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/266961 |
ISSN | 2023 Impact Factor: 14.8 2023 SCImago Journal Rankings: 4.102 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ettinger, David S. | - |
dc.contributor.author | Riely, Gregory J. | - |
dc.contributor.author | Akerley, Wallace | - |
dc.contributor.author | Borghaei, Hossein | - |
dc.contributor.author | Chang, Andrew C. | - |
dc.contributor.author | Cheney, Richard T. | - |
dc.contributor.author | Chirieac, Lucian R. | - |
dc.contributor.author | D'Amico, Thomas A. | - |
dc.contributor.author | Demmy, Todd L. | - |
dc.contributor.author | Govindan, Ramaswamy | - |
dc.contributor.author | Grannis, Frederic W. | - |
dc.contributor.author | Grant, Stefan C. | - |
dc.contributor.author | Horn, Leora | - |
dc.contributor.author | Jahan, Thierry M. | - |
dc.contributor.author | Komaki, Ritsuko | - |
dc.contributor.author | Kong, Feng Ming | - |
dc.contributor.author | Kris, Mark G. | - |
dc.contributor.author | Krug, Lee M. | - |
dc.contributor.author | Lackner, Rudy P. | - |
dc.contributor.author | Lennes, Inga T. | - |
dc.contributor.author | Loo, Billy W. | - |
dc.contributor.author | Martins, Renato | - |
dc.contributor.author | Otterson, Gregory A. | - |
dc.contributor.author | Patel, Jyoti D. | - |
dc.contributor.author | Pinder-Schenck, Mary C. | - |
dc.contributor.author | Pisters, Katherine M. | - |
dc.contributor.author | Reckamp, Karen | - |
dc.contributor.author | Rohren, Eric | - |
dc.contributor.author | Shapiro, Theresa A. | - |
dc.contributor.author | Swanson, Scott J. | - |
dc.contributor.author | Tauer, Kurt | - |
dc.contributor.author | Wood, Douglas E. | - |
dc.contributor.author | Yang, Stephen C. | - |
dc.contributor.author | Gregory, Kristina | - |
dc.contributor.author | Hughes, Miranda | - |
dc.date.accessioned | 2019-01-31T07:20:06Z | - |
dc.date.available | 2019-01-31T07:20:06Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | JNCCN Journal of the National Comprehensive Cancer Network, 2013, v. 11, n. 5, p. 562-576 | - |
dc.identifier.issn | 1540-1405 | - |
dc.identifier.uri | http://hdl.handle.net/10722/266961 | - |
dc.description.abstract | Masses in the anterior mediastinum can be neoplasms (eg, thymomas, thymic carcinomas, or lung metastases) or nonneoplastic conditions (eg, intrathoracic goiter). Thymomas are the most common primary tumor in the anterior mediastinum, although they are rare. Thymic carcinomas are very rare. Thymomas and thymic carcinomas originate in the thymus. Although thymomas can spread locally, they are much less invasive than thymic carcinomas. Patients with thymomas have 5-year survival rates of approximately 78%. However, 5-year survival rates for thymic carcinomas are only approximately 40%. These guidelines outline the evaluation, treatment, and management of these mediastinal tumors. Copyright © 2013 by the National Comprehensive Cancer Network. All rights reserved. | - |
dc.language | eng | - |
dc.relation.ispartof | JNCCN Journal of the National Comprehensive Cancer Network | - |
dc.title | Thymomas and thymic carcinomas | - |
dc.type | Article | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.6004/jnccn.2013.0072 | - |
dc.identifier.scopus | eid_2-s2.0-84877964841 | - |
dc.identifier.volume | 11 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 562 | - |
dc.identifier.epage | 576 | - |
dc.identifier.eissn | 1540-1413 | - |
dc.identifier.isi | WOS:000318752600007 | - |
dc.identifier.issnl | 1540-1405 | - |